Communicate with Supplier? Supplier
Kelly Ms. Kelly
What can I do for you?
+8613375313165
Chat Now
Chat Now Contact Supplier

 Shandong Haohong Biotechnology Co., Ltd.

All
  • All
  • Title
All
  • All
  • Title
HomeProductsActive Pharmaceutical Ingredient(API)Cabozantinib API

Cabozantinib API (Total 7 Products)

Product categories of Cabozantinib API, we are specialized manufacturers from China, Cabozantinib Xl184 Malate, 14C Cabozantinib Api suppliers/factory, wholesale high-quality products of Cabozantinib Xl184 Bms-907351 R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
Cabozantinib malate salt form

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name Cabozantinib malate XL184 IUPAC NAME 1 N 4 6 7 dimethoxyquinolin 4 yl oxyphenyl 1 N 4 fluorophenyl cyclopropane 1 1 dicarboxamide 2S 2 hydroxybutanedioic acid
Cabozantinib API Cas 1140909-48-3

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name Cabozantinib S Malate Cabozantinib malate XL184 Cometriq N 4 6 7 bis methyloxy quinolin 4 yl oxy phenyl N 4 fluorophenyl cyclopropane 1 1 dicarboxamide L malate N 4 6 7 bis methyloxy quinolin 4 yl oxy phenyl N 4 fluorophenyl...
Cabozantinib S Malate API

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name Cabozantinib malate XL184 Cometriq UNII DR7ST46X58 N 4 6 7 bis methyloxy quinolin 4 yl oxy phenyl N 4 fluorophenyl cyclopropane 1 1 dicarboxamide L malate N 4 6 7 bis methyloxy quinolin 4 yl oxy phenyl N 4 fluorophenyl cyclopropane 1 1...
Top Quality Best Price Cabozantinib API Cas 1140909-48-3

Unit Price: USD 1 / Kilogram

Min.Order Unit Price
1 Kilogram USD 1 / Kilogram

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name Cabozantinib malate XL184 Cometriq UNII DR7ST46X58 N 4 6 7 bis methyloxy quinolin 4 yl oxy phenyl N 4 fluorophenyl cyclopropane 1 1 dicarboxamide L malate N 4 6 7 bis methyloxy quinolin 4 yl oxy phenyl N 4 fluorophenyl cyclopropane 1 1...
Top Quality Best Price CAS 849217-68-1

Unit Price: USD 1 / Kilogram

Min.Order Unit Price
1 Kilogram USD 1 / Kilogram

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 60KG/MONTH

Product Name cabozantinib 14C Cabozantinib Cometriq Cabozantinib cyclopropane 1 1 dicarboxylic acid 4 6 7 dimethoxy quinoline 4 yloxy phenyl amide 4 fluoro phenyl amide 1 N 4 6 7 dimethoxyquinolin 4 yl oxyphenyl 1 N 4 fluorophenyl cyclopropane 1 1...
Cabozantinib API XL184 Malate

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 60KG/MONTH

Product Name cabozantinib 14C Cabozantinib Cometriq Cabozantinib cyclopropane 1 1 dicarboxylic acid 4 6 7 dimethoxy quinoline 4 yloxy phenyl amide 4 fluoro phenyl amide 1 N 4 6 7 dimethoxyquinolin 4 yl oxyphenyl 1 N 4 fluorophenyl cyclopropane 1 1...
Cabozantinib API Cas 849217-68-1

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 60KG/MONTH

Product Name cabozantinib 14C Cabozantinib Cometriq Cabozantinib cyclopropane 1 1 dicarboxylic acid 4 6 7 dimethoxy quinoline 4 yloxy phenyl amide 4 fluoro phenyl amide 1 N 4 6 7 dimethoxyquinolin 4 yl oxyphenyl 1 N 4 fluorophenyl cyclopropane 1 1...

China Cabozantinib API Suppliers

Cabozantinib is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.

Cabozantinib is a new molecular targeted drug developed by exelixis biopharmaceutical company in the United States. On November 29, 2012, the US Food and Drug Administration (FDA) approved cabotinib for the treatment of unresectable locally advanced or metastatic medullary thyroid carcinoma. In addition, sorafenib, van der nib and lovatinib are also approved by the food and Drug Administration (FDA) for the treatment of advanced thyroid cancer.

Home

Product

Whatsapp

About Us

Inquiry